Since EETs have anti-inflammatory and endothelial dysfunction-preventing effects, sEH inhibition reduces endothelial dysfunction and inflammation with the increase in EETs, and thus renal damage is mitigated. The gene discussed is EPHX2; the disease is endothelial dysfunction.